IndraLab

Statements


LD-MSP methylates CDKN2A. 1 / 1
| 1

reach
"Of 44 colorectal cancer patients, 30 (68%) exhibited abnormal promoter methylation of p16 in their serum DNA by LD-MSP, while 13 (30%) exhibited it by conventional MSP."